PBYI — Price & Forward EBITDA

Forward EBITDA (M)

Float Short %

10.71

Margin Of Safety %

Put/Call OI Ratio

0.05

EPS Next Q Diff

-0.19

EPS Last/This Y

-0.22

EPS This/Next Y

0.25

Price

6.98

Target Price

Analyst Recom

Performance Q

17.34

Upside

206.3%

Beta

1.2

Ticker: PBYI

20 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-03-09	PBYI	6.21	0.06	0.05	2818
2026-03-10	PBYI	6.06	0.07	2.78	2830
2026-03-11	PBYI	5.99	0.08	0.00	2856
2026-03-12	PBYI	5.88	0.08	999.99	2866
2026-03-13	PBYI	5.88	0.08	999.99	2866
2026-03-17	PBYI	6.13	0.09	0.00	2890
2026-03-18	PBYI	6.01	0.09	0.00	2885
2026-03-19	PBYI	6.15	0.09	0.00	2886
2026-03-20	PBYI	6.12	0.09	0.00	2837
2026-03-23	PBYI	6.27	0.11	0.00	1100
2026-03-24	PBYI	6.25	0.10	0.00	1202
2026-03-25	PBYI	6.34	0.08	0.00	1558
2026-03-26	PBYI	6.27	0.08	0.14	1569
2026-03-27	PBYI	6.08	0.08	0.00	1580
2026-03-30	PBYI	6.14	0.08	0.00	1600
2026-03-31	PBYI	6.4	0.07	0.00	1628
2026-04-01	PBYI	6.74	0.07	0.00	1659
2026-04-02	PBYI	6.91	0.06	0.00	2009
2026-04-06	PBYI	6.89	0.06	0.06	2064
2026-04-07	PBYI	6.97	0.05	0.00	2457
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

20 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-03-09	PBYI	6.22	-230.0	-	0.40
2026-03-10	PBYI	6.07	-230.0	-	0.40
2026-03-11	PBYI	6.00	-230.0	-	0.40
2026-03-12	PBYI	5.87	-230.0	-	0.40
2026-03-13	PBYI	5.90	-230.0	-	0.40
2026-03-17	PBYI	6.15	-230.0	-	0.40
2026-03-18	PBYI	6.01	-230.0	-	0.40
2026-03-19	PBYI	6.15	-230.0	-	0.40
2026-03-20	PBYI	6.13	-230.0	-	0.40
2026-03-23	PBYI	6.27	-230.0	-	0.40
2026-03-24	PBYI	6.25	-230.0	-	0.40
2026-03-25	PBYI	6.34	-230.0	-	0.40
2026-03-26	PBYI	6.26	-230.0	-	0.40
2026-03-27	PBYI	6.09	-230.0	-	0.40
2026-03-30	PBYI	6.13	-230.0	-	0.40
2026-03-31	PBYI	6.38	-230.0	-	0.40
2026-04-01	PBYI	6.74	-230.0	-	0.40
2026-04-02	PBYI	6.90	-230.0	-	0.40
2026-04-06	PBYI	6.89	-230.0	-	0.40
2026-04-07	PBYI	6.98	-230.0	-	0.40
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-03-09	PBYI	-0.59	2.31	9.55
2026-03-10	PBYI	-0.59	2.31	9.55
2026-03-11	PBYI	-0.59	2.31	9.81
2026-03-12	PBYI	-0.59	2.31	9.81
2026-03-13	PBYI	-0.59	2.31	9.81
2026-03-17	PBYI	-0.59	2.35	9.81
2026-03-18	PBYI	-0.59	2.35	9.81
2026-03-19	PBYI	-0.59	2.35	9.81
2026-03-20	PBYI	-0.59	2.35	9.81
2026-03-23	PBYI	-0.59	2.34	9.81
2026-03-24	PBYI	-0.59	2.34	9.81
2026-03-25	PBYI	-0.59	2.34	10.71
2026-03-26	PBYI	-0.59	2.34	10.71
2026-03-27	PBYI	-0.59	2.34	10.71
2026-03-30	PBYI	-0.59	2.35	10.71
2026-03-31	PBYI	-0.59	2.35	10.71
2026-04-01	PBYI	-0.59	2.35	10.71
2026-04-02	PBYI	-0.59	2.35	10.71
2026-04-06	PBYI	-0.59	2.34	10.71
2026-04-07	PBYI	-0.59	2.34	10.71
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

0.26

Avg. EPS Est. Current Quarter

-0.13

Avg. EPS Est. Next Quarter

0.07

Insider Transactions

-0.59

Institutional Transactions

2.34

Beta

1.2

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

8.55

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

41.6

Max Drawdown 5-Year %

-85.9

Target Price

P/E

11.41

Forward P/E

13.94

PEG

P/S

1.55

P/B

2.7

P/Free Cash Flow

8.5

EPS

0.61

Average EPS Est. Cur. Y

0.4

EPS Next Y. (Est.)

0.65

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

13.62

Relative Volume

0.75

Return on Equity vs Sector %

-3.6

Return on Equity vs Industry %

12.9

EPS 1 7Days Diff

-0.2

EPS 1 30Days Diff

-0.15

EBIT Estimation

◆ PBYI Healthcare

$6.97

📉

Swing / Pullback

Buy the dip on strong trends

WATCH

Trend

20/20

Pullback

8/25

Volume

9/15

Valuation

10/20

TP/AR

4/10

Options

8/10

RSI

63.3

Range 1M

96.6%

Sup Dist

3.6%

🚀

Momentum Growth

Ride accelerating trends

WEAK

Momentum

20/25

Growth

10/30

Estimates

8/20

Inst/Vol

7/15

Options

6/10

EPS Yr

-59%

EPS NY

100%

52W%

86.3%

💎

Long-Term Value

Quality companies, undervalued

WATCH

🟢 BUY +114.4% upside

Quality

26/30

Valuation

22/30

Growth

12/25

Stability

8/10

LT Trend

4/5

Upside

+114.4%

Quality

MoS

22%

Puma Biotechnology Inc

Sector: Healthcare

Industry: Biotechnology

Employees: 179

Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. It offers NERLYNX, an oral version of neratinib that is used to treat adult patients with early stage HER2-overexpressed/amplified breast cancer; and advanced or metastatic HER2-positive breast cancer when combined with capecitabine. The company also develops alisertib, a small molecule inhibitor of aurora kinase A for the treatment of hormone receptor positive breast cancer, triple negative breast cancer, small cell lung cancer, and head and neck cancer. It sells its products through specialty pharmacy and distributor networks. The company has license agreements with Pfizer Inc. for the development, manufacture, and commercialization of neratinib (oral), neratinib (intravenous), PB357, and related compounds, as well as sub-license agreements with Specialised Therapeutics Asia Pte Ltd., Medison Pharma Ltd., Pint Pharma International SA, Knight Therapeutics, Inc., Pierre Fabre Medicament SAS, and Bixink Therapeutics Co., Ltd. Puma Biotechnology, Inc. was founded in 2010 and is headquartered in Los Angeles, California.

PBYI

Latest News

—

Caricamento notizie per PBYI…

stock quote shares PBYI – Puma Biotechnology Inc. Stock Price stock today

news today PBYI – Puma Biotechnology Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch PBYI – Puma Biotechnology Inc. yahoo finance google finance

stock history PBYI – Puma Biotechnology Inc. invest stock market

stock prices PBYI premarket after hours

ticker PBYI fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: PBYI

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y